| Serial Number | 78638080 |
| Word Mark | SINDU PHARMACEUTICALS |
| Filing Date | Thursday, May 26, 2005 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, June 8, 2009 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 14, 2006 |
| Disclaimer with Predetermined Text | "Pharmaceuticals" |
| Goods and Services | pharmaceutical products intended for the treatment of infectious diseases, namely, bacterial, fungal, parasitic and viral infections, neoplastic disorders namely, hematologic cancer disorders and solid tumors, autoimmune disorders, namely, diabetes, arthritis, psoriasis, bone marrow and organ transplantation and immunosuppression, metabolic disorders namely, obesity and atherosclerosis, cardiovascular disorders namely, hypertension, congestive heart failure, myocardial infarction, angina and vascular diseases, renal disorders namely, acute and chronic renal failure and urinary disorders affecting renal conservation of water, central nervous system disorders namely, analgesia, anesthesia, hypnotics, sedatives, anxiety, psychosis, depression, mania, epilepsies, migraine, neurodegeneration, and drug addiction, inflammatory disorders namely, asthma, gout, inflammatory bowel disease, rheumatoid arthritis, gastrointestinal disorders namely, ulcers, emesis, diarrhea, irritable bowel syndrome, hormonal disorders affecting the thyroid, estrogens, progestins, androgens, glucocorticoids, insulin and glucose regulation, calcification and bone turnover, dermatological and opthalmological disorders |
| Goods and Services | pharmaceutical drug development services of pharmaceutical products intended for the treatment of infectious diseases, namely, bacterial, fungal, parasitic and viral infections, neoplastic disorders namely, hematologic cancer disorders and solid tumors, autoimmune disorders, namely, diabetes, arthritis, psoriasis, bone marrow and organ transplantation and immunosuppression, metabolic disorders namely, obesity and atherosclerosis, cardiovascular disorders namely, hypertension, congestive heart failure, myocardial infarction, angina and vascular diseases, renal disorders namely, acute and chronic renal failure and urinary disorders affecting renal conservation of water, central nervous system disorders namely, analgesia, anesthesia, hypnotics, sedatives, anxiety, psychosis, depression, mania, epilepsies, migraine, neurodegeneration, and drug addiction, inflammatory disorders namely, asthma, gout, inflammatory bowel disease, rheumatoid arthritis, gastrointestinal disorders namely, ulcers, emesis, diarrhea, irritable bowel syndrome, hormonal disorders affecting the thyroid, estrogens, progestins, androgens, glucocorticoids, insulin and glucose regulation, calcification and bone turnover, dermatological and opthalmological disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 6, 2005 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 6, 2005 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Indus Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Andover, MA 01810 |
| Party Name | Indus Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Andover, MA 01810 |
| Event Date | Event Description |
| Monday, June 8, 2009 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, June 8, 2009 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, November 7, 2008 | EXTENSION 5 GRANTED |
| Friday, November 7, 2008 | EXTENSION 5 FILED |
| Friday, November 7, 2008 | TEAS EXTENSION RECEIVED |
| Friday, May 9, 2008 | EXTENSION 4 GRANTED |
| Friday, May 9, 2008 | EXTENSION 4 FILED |
| Friday, May 9, 2008 | TEAS EXTENSION RECEIVED |
| Tuesday, November 6, 2007 | EXTENSION 3 GRANTED |
| Tuesday, November 6, 2007 | EXTENSION 3 FILED |
| Tuesday, November 6, 2007 | TEAS EXTENSION RECEIVED |
| Thursday, April 26, 2007 | EXTENSION 2 GRANTED |
| Thursday, April 26, 2007 | EXTENSION 2 FILED |
| Thursday, April 26, 2007 | TEAS EXTENSION RECEIVED |
| Thursday, November 9, 2006 | EXTENSION 1 GRANTED |
| Thursday, November 9, 2006 | EXTENSION 1 FILED |
| Thursday, November 9, 2006 | TEAS EXTENSION RECEIVED |
| Tuesday, May 9, 2006 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 14, 2006 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 25, 2006 | NOTICE OF PUBLICATION |
| Wednesday, January 4, 2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, December 30, 2005 | ASSIGNED TO LIE |
| Tuesday, December 20, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 20, 2005 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, December 20, 2005 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 20, 2005 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, December 19, 2005 | ASSIGNED TO EXAMINER |
| Monday, June 6, 2005 | NEW APPLICATION ENTERED IN TRAM |